In about 20–30% of all MTCs, germline mutations of the RET gene lead to hereditary MTC in the course of MEN2, whereas somatic RET mutations are mainly associated with sporadic MTC (approximately 50% of cases). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.